In this study, the mechanisms of FGF-2 in the development of COPD (especially emphysema) and the therapeutic potential of FGF2 were explored in a cigarette smoke-exposed C57BL/6 J emphysema mouse model. Here, FGF2 is linked to chronic obstructive pulmonary disease.